GHK-Cu Dosing Protocol: The Complete Copper Peptide Guide

GHK-Cu (copper peptide glycyl-L-histidyl-L-lysine) is one of the most versatile compounds in the peptide space — and one of the most misunderstood. If you're researching a GHK-Cu dosing protocol, you're probably coming from one of two directions: skincare and anti-aging (where it's been used in topical serums for decades), or the biohacking and injectable peptide world (where it stacks with Epithalon as a longevity protocol). This guide covers both — mechanism, dosing tables, injection steps, and the complete longevity stack.

GHK-Cu occurs naturally in human plasma, saliva, and urine. Levels peak in early adulthood and decline with age — from roughly 200 ng/mL at age 20 to under 80 ng/mL by age 60. That decline correlates with slowed wound healing, reduced collagen production, and accumulated tissue damage. Supplementing GHK-Cu is an attempt to restore those levels and the biological signaling that comes with them.

How GHK-Cu Works: Mechanism & Dual Action

GHK-Cu is a tripeptide (glycine, histidine, lysine) bound to a copper ion. The copper binding is not incidental — it's mechanistically essential. The copper complex allows GHK-Cu to act as a signal molecule, influencing gene expression at scale.

Core mechanisms:

• TGF-β pathway activation: GHK-Cu stimulates transforming growth factor-beta (TGF-β), which drives fibroblast activity and collagen synthesis. This is the primary mechanism behind wound healing and skin rejuvenation effects.
• Collagen synthesis upregulation: GHK-Cu directly stimulates collagen I, III, and IV production, along with elastin and decorin — structural proteins that determine skin firmness and tissue integrity.
• Broad gene expression modulation: Published research (Pickart & Margolina, 2018) shows GHK-Cu modulates over 4,000 human genes — including anti-inflammatory, antioxidant, and DNA repair pathways. This is the systemic longevity case for injectables.
• Neurological effects: Preclinical data suggests GHK-Cu may support nerve regeneration and has neuroprotective properties — making it interesting for users focused on cognitive longevity, not just skin.

The dual action is what distinguishes GHK-Cu from most peptides: topical application targets the skin directly (human clinical data exists here), while injectable GHK-Cu works systemically via bloodstream delivery, accessing the gene expression and tissue repair pathways at a body-wide level. Most research is animal/in vitro; topical GHK-Cu has the strongest human evidence.

GHK-Cu Dosing Protocol: Full Dosing Table

Copper peptide dosing depends heavily on route of administration and goal. Topical concentrations are measured in percentages; injectable doses are in milligrams. Don't conflate the two.

There is no established maximum dose for GHK-Cu in humans. The ranges above reflect common practitioner protocols and the injectable doses used in research contexts. Higher is not necessarily better — GHK-Cu works through signaling pathways that can saturate.

GHK-Cu Dosing Protocol: SubQ Injection Steps

Reconstitution

GHK-Cu comes as a lyophilized powder in vials — typically 5 mg or 10 mg. You'll need bacteriostatic water (BAC water) to reconstitute.

Standard concentration: 2 mg/mL

• 5 mg vial + 2.5 mL BAC water = 2 mg/mL
• 10 mg vial + 5.0 mL BAC water = 2 mg/mL

To reconstitute: inject BAC water slowly down the inside wall of the vial — not directly onto the powder. Swirl gently until dissolved. Do not shake.

Injection Technique

Recommended sites: Abdomen or outer thigh. Rotate between sites daily. Do not inject near the face — topical application is the appropriate delivery method for facial skin.

Storage:

• Unreconstituted: store in a cool, dry location away from light. Refrigeration preferred.
• Reconstituted: refrigerate at 2–8°C. Use within 28–30 days.
• Do not freeze reconstituted peptide.

Topical vs. Injectable GHK-Cu: Which Route Is Right for You?

GHK-Cu is one of the few peptides that has legitimate use cases in both topical and injectable form — but the goals are different enough that you should choose intentionally.

Topical GHK-Cu:

• Who it's for: Skincare enthusiasts, anti-aging users, anyone primarily targeting skin texture, fine lines, and collagen density
• Evidence base: The strongest human data exists here — multiple double-blind studies show topical GHK-Cu at 1–2% improves skin elasticity, density, and wound healing time
• Delivery format: Peptide cream serums or lotions; look for stable copper peptide formulations (blue-green color is a positive indicator of Cu²⁺ binding)

Injectable GHK-Cu:

• Who it's for: Biohackers stacking for systemic longevity, athletes targeting tissue repair and recovery, users running full peptide protocols
• Evidence base: Primarily preclinical (animal models and in vitro) for systemic use — the gene expression research is compelling but human injectable trials are limited
• Best paired with: Epithalon for longevity, or BPC-157 for wound healing and tissue repair acceleration

You can run both simultaneously — topical in the morning for skin, injectable SubQ for systemic effects. There's no known contraindication to combining routes.

GHK-Cu + Epithalon: The Longevity Stack

GHK-Cu and Epithalon are the two core components of the longevity peptide stack — and they're genuinely complementary, not redundant. Each works at a different level of biological organization:

• Epithalon: Operates at the chromosomal level — stimulates telomerase, supports telomere elongation, and regulates pineal/circadian function. It's the anti-aging play at the cellular root cause.
• GHK-Cu: Operates at the tissue and extracellular matrix level — collagen synthesis, wound repair, antioxidant gene upregulation, and broad anti-inflammatory signaling. It's the structural and repair component.

Together: Epithalon targets what's happening inside the cell (telomere health, chromosomal integrity), while GHK-Cu targets the tissue architecture and repair machinery outside the cell. Running them simultaneously creates a stack that addresses aging from both directions.

The full breakdown of longevity stacks — including how GHK-Cu and Epithalon fit into a broader protocol alongside GH peptides — is covered in the Best Peptide Stacks guide.

GHK-Cu Dosing Protocol: Cycle Length & What to Expect

GHK-Cu can be run as a short focused cycle (4 weeks) or a longer protocol (12 weeks), depending on your goal.

4-week protocol (topical-first users):

• Week 1: Minimal visible change. Skin may feel subtly more hydrated; no dramatic effects at this stage.
• Week 2: Skin texture changes begin — smoothness and firmness improvements are the first reported effects. Healing from minor cuts or abrasions noticeably faster.
• Weeks 3–4: Compounding skin benefits. Pore size reduction, improved elasticity, and reduction in fine lines are commonly reported. Injectable users may notice systemic anti-inflammatory effects.

12-week protocol (injectable longevity focus):

• Weeks 1–4: Baseline establishment. Skin and wound healing effects emerge (as above).
• Weeks 5–8: Continued collagen remodeling. Systemic users often report improved recovery from training, reduced joint inflammation, and a general sense of improved tissue resilience.
• Weeks 9–12: The cumulative effect period. Peak benefits in skin structural changes. For longevity users, this is the window where gene expression modulation compounds — though most of those effects aren't directly perceivable.

Honest caveat: GHK-Cu's skin benefits have solid human data. Its systemic/injectable longevity effects are supported by compelling preclinical research but limited human trials. Know what you're working with before setting expectations.

GHK-Cu Sourcing Checklist

Injectable peptide quality is not uniform across vendors. For a compound you're injecting, source matters more than price.

• ✓ Third-party Certificate of Analysis (CoA): HPLC purity and mass spectrometry confirmation of the correct sequence. Batch-specific, not generic.
• ✓ USA-based manufacturer: Domestic manufacturing means FDA oversight of the facility, even for research compounds. Offshore-only sourcing carries more risk.
• ✓ No fillers or additives: Injectable GHK-Cu should contain only the peptide and appropriate excipients (e.g., mannitol for lyophilization). Any unexpected ingredients are a red flag.
• ✓ Correct vial size and labeled concentration: GHK-Cu is commonly sold in 5 mg or 10 mg vials. Verify the labeled amount matches the CoA — mislabeling is a known quality issue.
• ✓ Verified review history: Look for vendor reputation in peptide-specific communities (not just generic review platforms). Longevity in the market and consistent user reports matter.

Frequently Asked Questions